ZymoGenetics (ZGEN) Reports Q3 Loss of $0.17
More News related to ZGEN
- ZymoGenetics to Webcast Presentation at the Piper Jaffray Healthcare Conference
- Trading Outlook for ZymoGenetics Inc. Issued by StockPreacher.com
- Morning Movers 11/06: ACLS, CVM, ZIOP, LPSN, CABL, ZGEN Higher; NHWK, GOK, CROX, CVI, RAIL, CSTR Lower
- Wedbush Upgrades ZymoGenetics (ZGEN) to Outperform; Believe ZGEN on Track to Meet 2010 Sales Estimates
- ZymoGenetics (ZGEN) Reports Q3 Loss of $0.17
More News related to Earnings
- Taseko Mines (TGB) to Receive $180 Million to Joint Venture 25% of Gibraltar Mine
- Lockheed Martin (LMT) and Microsoft (MSFT) Announce Simulator Licensing Agreement
- MedQuist (MEDQ) To Feature SpeechQ VTB for Radiology at RSNA Conference
- Alcatel-Lucent (ALU) Gains Service Provider Router Market Share for the Fifth Consecutive Quarter
- MedQuist (MEDQ) Signs License Agreement with Nuance Communications (NUAN)
ZymoGenetics Inc. (NASDAQ: ZGEN) reports Q3 loss of $0.17, 3 cents better than the analyst estimate of ($0.20). Revenue for the quarter was $27.5 million, which compares to the estimate of $31.52 million.
Related Categories
EarningsStocks Mentioned
+0.54Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
